{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68163-066",
      "generic_name": "Acetaminophen, Aspirin (NSAID), Caffeine",
      "labeler_name": "Raritan Pharmaceuticals Inc.",
      "brand_name": "DRX CHOICE Extra Strength Headache Relief",
      "brand_name_suffix": "Extra Strength Headache Relief",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "250 mg/1"
        },
        {
          "name": "ASPIRIN",
          "strength": "250 mg/1"
        },
        {
          "name": "CAFFEINE",
          "strength": "65 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68163-066-24",
          "description": "24 TABLET, FILM COATED in 1 CARTON (68163-066-24)",
          "marketing_start_date": "20260814",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "05f96258-7352-4cd3-96ad-b5bba5c510d0",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260814",
      "product_id": "68163-066_05f96258-7352-4cd3-96ad-b5bba5c510d0",
      "application_number": "M013",
      "brand_name_base": "DRX CHOICE",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Central Nervous System Stimulant [EPC]",
        "Central Nervous System Stimulation [PE]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Methylxanthine [EPC]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]",
        "Xanthines [CS]"
      ]
    }
  ]
}